A crosstalk between hSiah2 and Pias E3-ligases modulates Pias-dependent activation

Oncogene

Volumn 26, Issue 46, 2007, Pages 6665-6676

  Depaux, A ^a,b   Regnier Ricard, F ^a,b   Germani, A ^a,b,c   Varin Blank, N ^a,b  

^a INSTITUT COCHIN   (France)

^b INSERM   (France)

^c LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

Pias; Proteasome; Siah; Ubiquitination

Indexed keywords

PEPTIDE; PROTEASOME; PROTEIN HSIAH; PROTEIN INHIBITOR OF ACTIVATED STAT; STAT PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SUMO PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; CONTROLLED STUDY; ENZYME REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SUMOYLATION; UBIQUITINATION;

CELL LINE; CELL NUCLEUS; GENE EXPRESSION REGULATION; HUMANS; MAP KINASE KINASE 4; NUCLEAR PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN INHIBITORS OF ACTIVATED STAT; PROTO-ONCOGENE PROTEINS C-JUN; SUMO-1 PROTEIN; TRANS-ACTIVATION (GENETICS); UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 35348828426     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210486     Document Type: Article

References (50)

1. Chung CD, Liao J, Liu B, Rao X, Jay P, Berta P et al. (1997). Specific inhibition of Stat3 signal transduction by PIAS3. Science 278: 1803-1805.
2. Della NG, Senior PV, Bowtell DD. (1993). Isolation and characterisation of murine homologues of the Drosophila seven in absentia gene (sina). Development 117: 1333-1343.
3. Depaux A, Regnier-Ricard F, Germani A, Varin-Blank N. (2006). Dimerization of hSiah proteins regulates their stability. Biochem Biophys Res Commun 348: 857-863.
4. Desterro JM, Rodriguez MS, Kemp GD, Hay RT. (1999). Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1. J Biol Chem 274: 10618-10624.
5. Desterro JM, Thomson J, Hay RT. (1997). Ubch9 conjugates SUMO but not ubiquitin. FEBS Lett 417: 297-300.
6. Driscoll J, Goldberg AL. (1990). The proteasome (multicatalytic protease) is a component of the 1500-kDa proteolytic complex which degrades ubiquitin-conjugated proteins. J Biol Chem 265: 4789-4792.
7. Duval D, Duval G, Kedinger C, Poch O, Boeuf H. (2003). The 'PINIT' motif, of a newly identified conserved domain of the PIAS protein family, is essential for nuclear retention of PIAS3L. FEBS Lett 554: 111-118.
8. Floyd ZE, Trausch-Azar JS, Reinstein E, Ciechanover A, Schwartz AL. (2001). The nuclear ubiquitin-proteasome system degrades MyoD. J Biol Chem 276: 22468-22475.
9. Fogal V, Gostissa M, Sandy P, Zacchi P, Sternsdorf T, Jensen K et al. (2000). Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J 19: 6185-6195.
10. Freemont PS. (2000). RING for destruction? Curr Biol 10: R84-7.
11. Germani A, Bruzzoni-Giovanelli H, Fellous A, Gisselbrecht S, Varin-Blank N, Calvo F. (2000). SIAH-1 interacts with alpha-tubulin and degrades the kinesin Kid by the proteasome pathway during mitosis. Oncogene 19: 5997-6006.
12. Germani A, Prabel A, Mourah S, Podgorniak MP, Di Carlo A, Ehrlich R et al. (2003). SIAH-1 interacts with CtIP and promotes its degradation by the proteasome pathway. Oncogene 22: 8845-8851.
13. Germani A, Romero F, Houlard M, Camonis J, Gisselbrecht S, Fischer S et al. (1999). hSiah2 is a new Vav binding protein which inhibits Vav-mediated signaling pathways. Mol Cell Biol 19: 3798-3807.
14. Gross M, Liu B, Tan JA, French FS, Carey M, Shuai K. (2001). Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells. Oncogene 20: 3880-3887.
15. Habelhah H, Frew IJ, Laine A, Janes PW, Relaix F, Sassoon D et al. (2002). Stress-induced decrease in TRAF2 stability is mediated by Siah2. EMBO J 21: 5756-5765.
16. House CM, Frew IJ, Huang HL, Wiche G, Traficante N, Nice E et al. (2003). A binding motif for Siah ubiquitin ligase. Proc Natl Acad Sci USA 100: 3101-3106.
17. Hu G, Chung YL, Glover T, Valentine V, Look AT, Fearon ER. (1997a). Characterization of human homologs of the Drosophila seven in absentia (sina) gene. Genomics 46: 103-111.
18. Hu G, Zhang S, Vidal M, Baer JL, Xu T, Fearon ER. (1997b). Mammalian homologs of seven in absentia regulate DCC via the ubiquitin-proteasome pathway. Genes Dev 11: 2701-2714.
19. Johnson ES, Gupta AA. (2001). An E3-like factor that promotes SUMO conjugation to the yeast septins. Cell 106: 735-744.
20. Kahyo T, Nishida T, Yasuda H. (2001). Involvement of PIAS1 in the sumoylation of tumor suppressor p53. Mol Cell 8: 713-718.
21. Kotaja N, Vihinen M, Palvimo JJ, Janne OA. (2002). Androgen receptor-interacting protein 3 and other PIAS proteins cooperate with glucocorticoid receptor-interacting protein 1 in steroid receptor-dependent signaling. J Biol Chem 277: 17781-17788.
22. Lallemand-Breitenbach V, Zhu J, Puvion F, Koken M, Honore N, Doubeikovsky A et al. (2001). Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation. J Exp Med 193: 1361-1371.
23. Liu B, Gross M, ten Hoeve J, Shuai K. (2001a). A transcriptional corepressor of Stat1 with an essential LXXLL signature motif. Proc Natl Acad Sci USA 98: 3203-3207.
24. Liu B, Liao J, Rao X, Kushner SA, Chung CD, Chang DD et al. (1998). Inhibition of Stat1-mediated gene activation by PIAS1. Proc Natl Acad Sci USA 95: 10626-10631.
25. Liu B, Shuai K. (2001). Induction of apoptosis by protein inhibitor of activated Stat1 through c-Jun NH2-terminal kinase activation. J Biol Chem 276: 36624-36631.
26. Liu J, Stevens J, Rote CA, Yost HJ, Hu Y, Neufeld KL et al. (2001b). Siah-1 mediates a novel beta-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein. Mol Cell 7: 927-936.
27. Liu YC. (2004). Ubiquitin ligases and the immune response. Annu Rev Immunol 22: 81-127.
28. Matsuzawa SI, Reed JC. (2001). Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. Mol Cell 7: 915-926.
29. Megidish T, Xu JH, Xu CW. (2002). Activation of p53 by protein inhibitor of activated Stat1 (PIAS1). J Biol Chem 277: 8255-8259.
30. Melchior F. (2000). SUMO- non classical ubiquitin. Annu Rev Cell Dev Biol 16: 591-626.
31. Millot GA, Feger F, Garcon L, Vainchenker W, Dumenil D, Svinarchuk F. (2002). MplK, a natural variant of the thrombopoietin receptor with a truncated cytoplasmic domain, binds thrombopoietin but does not interfere with thrombopoietin-mediated cell growth. Exp Hematol 30: 166-175.
32. Muller S, Berger M, Lehembre F, Seeler JS, Haupt Y, Dejean A. (2000). c-Jun and p53 activity is modulated by SUMO-1 modification. J Biol Chem 275: 13321-13329.
33. Muller S, Matunis MJ, Dejean A. (1998). Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J 17: 61-70.
34. Nakayama K, Ronai Z. (2004). Siah: new players in the cellular response to hypoxia. Cell Cycle 3: 1345-1347.
35. Polekhina G, House CM, Traficante N, Mackay JP, Relaix F, Sassoon DA et al. (2002). Siah ubiquitin ligase is structurally related to TRAF and modulates TNF-alpha signaling. Nat Struct Biol 9: 68-75.
36. Reed JC, Ely KR. (2002). Degrading liaisons: Siah structure revealed. Nat Struct Biol 9: 8-10.
37. Rodriguez MS, Desterro JM, Lain S, Midgley CA, Lane DP, Hay RT. (1999). SUMO-1 modification activates the transcriptional response of p53. EMBO J 18: 6455-6461.
38. Sachdev S, Bruhn L, Sieber H, Pichler A, Melchior F, Grosschedl R. (2001). PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes Dev 15: 3088-3103.
39. Schmidt D, Muller S. (2002). Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity. Proc Natl Acad Sci USA 99: 2872-2877.
40. Shuai K, Liu B. (2005). Regulation of gene-activation pathways by PIAS proteins in the immune system. Nat Rev Immunol 5: 593-605.
41. Simon MC. (2004). Siah proteins, HIF prolyl hydroxylases, and the physiological response to hypoxia. Cell 117: 851-853.
42. Sun L, Chen ZJ. (2004). The novel functions of ubiquitination in signaling. Curr Opin Cell Biol 16: 119-126.
43. Susini L, Passer BJ, Amzallag-Elbaz N, Juven-Gershon T, Prieur S, Privat N et al. (2001). Siah-1 binds and regulates the function of Numb. Proc Natl Acad Sci USA 98: 15067-15072.
44. Tan JA, Hall SH, Hamil KG, Grossman G, Petrusz P, French FS. (2002). Protein inhibitors of activated STAT resemble scaffold attachment factors and function as interacting nuclear receptor coregulators. J Biol Chem 277: 16993-17001.
45. Tang AH, Neufeld TP, Kwan E, Rubin GM. (1997). PHYL acts to down-regulate TTK88, a transcriptional repressor of neuronal cell fates, by a SINA-dependent mechanism. Cell 90: 459-467.
46. Tanikawa J, Ichikawa-Iwata E, Kanei-Ishii C, Nakai A, Matsuzawa SI, Reed JC et al. (2000). p53 suppresses the c-Myb-induced activation of heat shock transcription factor 3. J Biol Chem 275: 15578-15585.
47. Weissman AM. (2001). Themes and variations on ubiquitylation. Nat Rev Mol Cell Biol 2: 169-178.
48. Yaron A, Gonen H, Alkalay I, Hatzubai A, Jung S, Beyth S et al. (1997). Inhibition of NF-kappa-B cellular function via specific targeting of the I-kappa-B-ubiquitin ligase. EMBO J 16: 6486-6494.
49. Yeh WC, Shahinian A, Speiser D, Kraunus J, Billia F, Wakeham A et al. (1997). Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7: 715-725.
50. Zhang J, Guenther MG, Carthew RW, Lazar MA. (1998). Proteasomal regulation of nuclear receptor corepressor-mediated repression. Genes Dev 12: 1775-1780.